Check out the Detailed Program! Learn More

Esophageal Motility Disorders in Systemic Sclerosis

Systemic sclerosis (SSc), also called scleroderma, can affect the gastrointestinal tract from the mouth to the colon. The esophagus is one of the most frequently involved organs, and impaired movement may develop even when skin or other organ symptoms appear limited. Recognizing esophageal involvement early helps clinicians address nutrition, reflux injury, aspiration risk, and declining quality of life.

The condition reflects a combination of smooth-muscle atrophy, vascular injury, fibrosis, and damage to the enteric nervous system. These changes can weaken peristalsis and reduce lower esophageal sphincter pressure. As a result, food and liquid may move slowly while stomach contents can flow backward into the esophagus.

Scientific congresses focused on esophageal disease, including educational programs associated with ISDE 2021, have emphasized the value of coordinated assessment. Rheumatologists, gastroenterologists, surgeons, speech and swallowing specialists, and dietitians may all contribute to effective care.

Why Systemic Sclerosis Affects Esophageal Function

Early vascular and neural changes may interfere with coordinated contractions. Over time, smooth-muscle replacement by fibrotic tissue can produce weak or absent peristalsis. The lower esophageal sphincter may also become hypotensive, allowing acid and bile reflux to occur more easily.

The severity of gastrointestinal disease does not always match the extent of skin thickening or other systemic findings. Some patients have substantial esophageal dysfunction with few symptoms, while others report severe heartburn, regurgitation, or swallowing difficulty. Routine clinical attention is therefore important even when complaints seem mild.

Common Symptoms And Complications

Heartburn and acid regurgitation are frequent manifestations. Patients may describe a sour taste, chest discomfort after meals, nighttime coughing, or symptoms that worsen when lying down. Dysphagia can involve solids, liquids, or both, depending on the underlying motility pattern and the presence of narrowing.

Poor clearance of refluxate can expose the esophageal lining to prolonged acid contact. Complications may include erosive esophagitis, peptic strictures, Barrett’s esophagus, and, in some cases, aspiration-related respiratory problems. Bloating, early satiety, weight loss, and malnutrition may point to broader gastrointestinal involvement.

Diagnostic Tools For Esophageal Dysmotility

Upper endoscopy evaluates mucosal injury, strictures, rings, infection, and Barrett’s-related changes. It can also help exclude mechanical obstruction when a patient reports progressive dysphagia. A normal endoscopic appearance, however, does not rule out a movement disorder.

High-resolution esophageal manometry is central to physiologic assessment. Typical findings may include absent or weak distal contractions and reduced lower esophageal sphincter pressure. Ambulatory pH or impedance monitoring can quantify acid and non-acid reflux, especially when symptoms persist despite treatment. Barium esophagram and timed contrast studies may add information about transit and structural narrowing.

Recognizing Different Motility Patterns

Esophageal dysfunction in SSc often progresses gradually, but patterns vary. Some patients retain partial contractile activity, whereas others develop severe hypomotility or an aperistaltic esophagus. Reflux may dominate the clinical picture even before swallowing problems become obvious.

Feature Predominant reflux pattern Hypomotility pattern Advanced clearance failure
Main physiologic change Low sphincter pressure Weak peristaltic contractions Minimal or absent propulsion
Typical symptoms Heartburn, regurgitation Intermittent dysphagia, chest discomfort Dysphagia, food retention, weight loss
Useful tests Endoscopy, pH monitoring High-resolution manometry Manometry, timed barium study
Important risks Esophagitis, Barrett’s esophagus Reflux with poor clearance Stricture, aspiration, malnutrition
Treatment focus Reflux suppression and positioning Reflux control and meal modification Specialist care, nutrition, complication management

Medical And Supportive Management

Treatment is individualized according to symptoms, test results, mucosal damage, nutritional status, and other organ involvement. Proton pump inhibitors are commonly used for clinically significant gastroesophageal reflux, while H2-receptor antagonists may have a role in selected patients. Medication timing and adherence should be reviewed before labeling reflux as treatment-resistant.

Lifestyle measures can support symptom control. Smaller meals, careful chewing, remaining upright after eating, elevating the head of the bed, and avoiding personal trigger foods may reduce reflux exposure. Tobacco, alcohol, late meals, and medicines that irritate the esophagus should be reviewed with a clinician.

Prokinetic therapy may be considered in selected cases, although benefits and adverse effects vary. Endoscopic dilation can treat a clinically important stricture. Surgery requires particular caution because severe dysmotility may worsen postoperative swallowing or reflux; decisions should be made by an experienced multidisciplinary team.

Priorities For Clinical Follow-Up

Ongoing review is useful because esophageal disease can evolve and symptoms may be misleading. Care should address swallowing, reflux control, respiratory symptoms, body weight, anemia, and dietary intake rather than focusing on a single test result.

Patients should receive clear instructions about alarm symptoms and when to seek prompt evaluation. New or progressive dysphagia, vomiting, gastrointestinal bleeding, unintentional weight loss, persistent chest pain, or recurrent nighttime coughing deserves medical assessment.

Practical priorities include:

  • Arrange endoscopy for alarm symptoms, suspected mucosal injury, or persistent dysphagia.
  • Use high-resolution manometry when a motility disorder is suspected after structural disease is assessed.
  • Monitor weight, hydration, nutritional intake, and signs of aspiration.
  • Coordinate reflux treatment with rheumatology and gastroenterology care.
  • Reassess symptoms when systemic sclerosis or gastrointestinal involvement changes.

Esophageal involvement is a major part of gastrointestinal care in systemic sclerosis, but it can be managed more effectively when detected before complications become advanced. Educational resources and scientific discussions from the International Society for Diseases of the Esophagus can help clinicians stay informed about evolving diagnostic methods and treatment strategies. Explore the ISDE 2021 congress materials and related esophageal disease research to deepen understanding of motility disorders and multidisciplinary care.

About ISDE

The ISDE is an international, multispecialty society devoted to the study of the esophagus in disease and in health that was founded in 1979. The aims of the ISDE are to promote the exchange of scientific and medical knowledge among specialists in the field, to maintain interchange with organizations and industries, and to encourage basic and clinical research in fields related to the esophagus. In order to promote the professional and educational development of individuals interested in the esophagus, the ISDE sponsors its own journal, international congresses, and other educational programs. The ISDE Secretariat was in Tokyo, Japan, from 1979 to 2004, and then resided in Los Angeles, California, from 2004 through 2010. Since 2010 the Secretariat has been in Vancouver, British Columbia, under the auspices of International Conferences Service, Ltd. The ISDE welcomes participation by existing members and encourages individuals who are professionally interested in the esophagus to become members. Benefits include reduced registration fees at our congresses and other educational offerings, restricted access to website content and member search capability, access to webcasts, reduced subscription rates for our journal, and the opportunity to help lead this organization into a position of leadership in the worldwide medical community.